01 1Assia Chemical Industries Ltd - Teva Tech Site
02 2CHONGQING HUAPONT SHENGCHEM PHARM. CO., INC.
03 3CHONGQING HUAPONT SHENGCHEM PHARM. CO., LTD.
04 2Cerbios-Pharma SA
05 1DARMERICA, LLC
06 1Fagron Inc
07 2Formosa Laboratories, Inc.
08 1LETCO MEDICAL, LLC
09 1Sigma-Aldrich Corporation
01 3CALCIPOTRIENE ANHYDROUS
02 3CALCIPOTRIENE MONOHYDRATE
03 4Calcipotriene
04 2Calcipotriene Monohydrate
05 1Calcipotriol Anhydrous
06 1Calcipotriol Monohydrate
01 5China
02 1Israel
03 1Netherlands
04 2Switzerland
05 2Taiwan
06 3U.S.A
NDC Package Code : 54239-015
Start Marketing Date : 2016-06-28
End Marketing Date : 2025-12-31
Dosage Form (Strength) : POWDER (1g/g)
Marketing Category : BULK INGREDIENT
NDC Package Code : 54239-005
Start Marketing Date : 2009-09-01
End Marketing Date : 2025-12-31
Dosage Form (Strength) : POWDER (1g/g)
Marketing Category : BULK INGREDIENT
NDC Package Code : 48943-0026
Start Marketing Date : 2016-06-09
End Marketing Date : 2025-12-31
Dosage Form (Strength) : POWDER (1g/g)
Marketing Category : BULK INGREDIENT
NDC Package Code : 48943-0022
Start Marketing Date : 2016-06-09
End Marketing Date : 2025-12-31
Dosage Form (Strength) : POWDER (1g/g)
Marketing Category : BULK INGREDIENT
NDC Package Code : 48943-0030
Start Marketing Date : 2016-06-09
End Marketing Date : 2025-12-31
Dosage Form (Strength) : POWDER (1kg/kg)
Marketing Category : BULK INGREDIENT
NDC Package Code : 48943-0023
Start Marketing Date : 2016-06-09
End Marketing Date : 2025-12-31
Dosage Form (Strength) : POWDER (1g/g)
Marketing Category : BULK INGREDIENT
NDC Package Code : 48943-0032
Start Marketing Date : 2016-06-09
End Marketing Date : 2025-12-31
Dosage Form (Strength) : POWDER (1kg/kg)
Marketing Category : BULK INGREDIENT
NDC Package Code : 51552-1458
Start Marketing Date : 2016-09-15
End Marketing Date : 2025-01-27
Dosage Form (Strength) : POWDER (1g/g)
Marketing Category : BULK INGREDIENT FOR HUMAN P...
NDC Package Code : 62991-3192
Start Marketing Date : 2023-07-27
End Marketing Date : 2025-12-31
Dosage Form (Strength) : POWDER (1g/g)
Marketing Category : BULK INGREDIENT FOR HUMAN P...
NDC Package Code : 58272-197
Start Marketing Date : 2003-08-01
End Marketing Date : 2025-12-31
Dosage Form (Strength) : POWDER (1g/g)
Marketing Category : BULK INGREDIENT
A Calcipotriene manufacturer is defined as any person or entity involved in the manufacture, preparation, processing, compounding or propagation of Calcipotriene, including repackagers and relabelers. The FDA regulates Calcipotriene manufacturers to ensure that their products comply with relevant laws and regulations and are safe and effective to use. Calcipotriene API Manufacturers are required to adhere to Good Manufacturing Practices (GMP) to ensure that their products are consistently manufactured to meet established quality criteria.
click here to find a list of Calcipotriene manufacturers with USDMF, JDMF, KDMF, CEP, GMP, COA and API Price related information on PhamaCompass.
A Calcipotriene supplier is an individual or a company that provides Calcipotriene active pharmaceutical ingredient (API) or Calcipotriene finished formulations upon request. The Calcipotriene suppliers may include Calcipotriene API manufacturers, exporters, distributors and traders.
click here to find a list of Calcipotriene suppliers with USDMF, JDMF, KDMF, CEP, GMP, COA and API Price related information on PharmaCompass.
National Drug Code is a comprehensive database maintained by the FDA that contains information on all drugs marketed in the US. This directory includes information about finished drug products, unfinished drug products, and compounded drug products, including those containing Calcipotriene as an active pharmaceutical ingredient (API).
The FDA updates the NDC directory daily. The NDC numbers for Calcipotriene API and other APIs are published in this directory by the FDA.
The NDC unfinished drugs database includes product listing information submitted for all unfinished drugs, such as active pharmaceutical ingredients (APIs), drugs intended for further processing and bulk drug substances for compounding.
Pharmaceutical companies that manufacture Calcipotriene as an active pharmaceutical ingredient (API) must furnish the FDA with an updated record of all drugs that they produce, prepare, propagate, compound, or process for commercial distribution in the US at their facilities.
The NDC directory also contains data on finished compounded human drug products that contain Calcipotriene and are produced by outsourcing facilities. While these outsourcing facilities are not mandated to assign a Calcipotriene NDC to their finished compounded human drug products, they may choose to do so.
click here to find a list of Calcipotriene suppliers with NDC on PharmaCompass.
We have 8 companies offering Calcipotriene
Get in contact with the supplier of your choice:
LOOKING FOR A SUPPLIER?
